Careers  |  Sign In  |  Register  |   Twitter

New Novartis Heart Failure Drug Lowers Death, Hospitalization by 20 Percent

LCZ696, Novartis‘ new drug is breaking barriers in heart failure, and reducing the risk of death or hospitalization by an impressive 20 percent, an article published by CBS News reports. According to Dr. Clyde Yancy, chief of cardiology at Northwestern University and former president of the American Heart Association, this drug has been the biggest breakthrough in cardiology in a decade. The study, published in the New England Journal of Medicine, involved 8,500 participants from 47 countries, and found that the chances of dying of heart-related causes was reduced by 20 percent over a 27-month period.

Read the article published by CBS News.

Read the study published in the New England Journal of Medicine.